374 related articles for article (PubMed ID: 21081501)
1. The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein.
Delarasse C; Auger R; Gonnord P; Fontaine B; Kanellopoulos JM
J Biol Chem; 2011 Jan; 286(4):2596-606. PubMed ID: 21081501
[TBL] [Abstract][Full Text] [Related]
2. Ezrin/radixin/moesin are required for the purinergic P2X7 receptor (P2X7R)-dependent processing of the amyloid precursor protein.
Darmellah A; Rayah A; Auger R; Cuif MH; Prigent M; Arpin M; Alcover A; Delarasse C; Kanellopoulos JM
J Biol Chem; 2012 Oct; 287(41):34583-95. PubMed ID: 22891241
[TBL] [Abstract][Full Text] [Related]
3. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
4. Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.
Milosch N; Tanriöver G; Kundu A; Rami A; François JC; Baumkötter F; Weyer SW; Samanta A; Jäschke A; Brod F; Buchholz CJ; Kins S; Behl C; Müller UC; Kögel D
Cell Death Dis; 2014 Aug; 5(8):e1391. PubMed ID: 25165877
[TBL] [Abstract][Full Text] [Related]
5. η-Secretase processing of APP inhibits neuronal activity in the hippocampus.
Willem M; Tahirovic S; Busche MA; Ovsepian SV; Chafai M; Kootar S; Hornburg D; Evans LD; Moore S; Daria A; Hampel H; Müller V; Giudici C; Nuscher B; Wenninger-Weinzierl A; Kremmer E; Heneka MT; Thal DR; Giedraitis V; Lannfelt L; Müller U; Livesey FJ; Meissner F; Herms J; Konnerth A; Marie H; Haass C
Nature; 2015 Oct; 526(7573):443-7. PubMed ID: 26322584
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of P2X7 and P2Y2 nucleotide receptors on α-secretase-dependent APP processing in Neuro-2a cells.
León-Otegui M; Gómez-Villafuertes R; Díaz-Hernández JI; Díaz-Hernández M; Miras-Portugal MT; Gualix J
FEBS Lett; 2011 Jul; 585(14):2255-62. PubMed ID: 21651910
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells.
Woods NK; Padmanabhan J
J Biol Chem; 2013 Oct; 288(42):30114-30124. PubMed ID: 24022491
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
9. Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines.
Colombo A; Wang H; Kuhn PH; Page R; Kremmer E; Dempsey PJ; Crawford HC; Lichtenthaler SF
Neurobiol Dis; 2013 Jan; 49():137-47. PubMed ID: 22940630
[TBL] [Abstract][Full Text] [Related]
10. P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing.
Camden JM; Schrader AM; Camden RE; González FA; Erb L; Seye CI; Weisman GA
J Biol Chem; 2005 May; 280(19):18696-702. PubMed ID: 15778502
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase.
Bandyopadhyay S; Hartley DM; Cahill CM; Lahiri DK; Chattopadhyay N; Rogers JT
J Neurosci Res; 2006 Jul; 84(1):106-18. PubMed ID: 16724341
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model.
Guo C; Yang ZH; Zhang S; Chai R; Xue H; Zhang YH; Li JY; Wang ZY
Neuropsychopharmacology; 2017 Dec; 42(13):2504-2515. PubMed ID: 28079060
[TBL] [Abstract][Full Text] [Related]
13. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.
Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF
PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases.
Jacobsen KT; Adlerz L; Multhaup G; Iverfeldt K
J Biol Chem; 2010 Apr; 285(14):10223-31. PubMed ID: 20139073
[TBL] [Abstract][Full Text] [Related]
15. Alcadein cleavages by amyloid beta-precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related gamma-secretase dysfunction.
Hata S; Fujishige S; Araki Y; Kato N; Araseki M; Nishimura M; Hartmann D; Saftig P; Fahrenholz F; Taniguchi M; Urakami K; Akatsu H; Martins RN; Yamamoto K; Maeda M; Yamamoto T; Nakaya T; Gandy S; Suzuki T
J Biol Chem; 2009 Dec; 284(52):36024-36033. PubMed ID: 19864413
[TBL] [Abstract][Full Text] [Related]
16. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.
Carey RM; Blusztajn JK; Slack BE
BMC Cell Biol; 2011 May; 12():20. PubMed ID: 21586144
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of alpha-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin.
Hiraoka Y; Ohno M; Yoshida K; Okawa K; Tomimoto H; Kita T; Nishi E
J Neurochem; 2007 Sep; 102(5):1595-1605. PubMed ID: 17555553
[TBL] [Abstract][Full Text] [Related]
18. Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization.
Gandhi S; Refolo LM; Sambamurti K
J Mol Neurosci; 2004; 24(1):137-43. PubMed ID: 15314262
[TBL] [Abstract][Full Text] [Related]
19. A closer look at alpha-secretase.
Postina R
Curr Alzheimer Res; 2008 Apr; 5(2):179-86. PubMed ID: 18393803
[TBL] [Abstract][Full Text] [Related]
20. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.
Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT
Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
